You can buy or sell Chemours and other stocks, options, ETFs, and crypto commission-free!
The Chemours Company, also called Chemours, is a holding company, which engages in the provision of performance chemicals. It operates through the following segments: Titanium Technologies, Fluoroproducts, Chemical Solutions, and Corporate and Other. Read More The Titanium Technologies segment produces titanium dioxide. The Fluoroproducts segment supplies refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment provides chemicals used in gold production, oil refining, agriculture, and industrial polymers. The Corporate and Other covers corporate costs and certain legal and environmental expenses that are not allocated to the segments. The firm offers refrigerants, industrial fluoropolymer resins, sodium cyanide, performance chemicals and intermediates, and titanium dioxide pigments to the plastics and coatings, refrigeration and air conditioning, general industrial, electronics, mining, and oil refining markets. The company was founded on February 18, 2014 and is headquartered in Wilmington, Delaware.
52 Week High
52 Week Low
Stock Highlights: Chemours Company (NYSE: CC)
Chemours Company is part of the chemicals industry and trades as part of the basic materials sector. The company CEO is Mark P. Vergnano. The Chemours Co is a chemical manufacturing company that produces and develops titanium technologies, fluoroproducts and chemical solutions. It also produces refrigerants and industrial resins. Previous Intraday Trading Performance: The CC stock showed a previous change of 2.98% with an open at 37.78 and a close of 39.02. It reached an intraday high of 39.18 and a low o...
Yahoo FinanceMar 16
Chemours (CC) Down 2.1% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for Chemours (CC). Shares have lost about 2.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Chemours due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. Chemours’ Q4 Earnings In Line, Revenues Trail Estimates ...
Simply Wall StMar 15
The Chemours Company (NYSE:CC): Are Analysts’ Forecast Signalling Trouble Ahead?
Based on The Chemours Company’s (NYSE:CC) recently announced earnings update on 31 December 2018, analyst forecasts appear to be pessimistic, with earnings expected to decline by -18% in the upcoming year relative to the past 5-year average growth rate of 37%. With trailing-twelve-month net income at current levels of US$995m, the consensus growth rate suggests that earnings will decline to US$820m by 2020. Below is a brief commentary around Chemours’s earnings outlook going forward, which may give you a sense of market sentiment for the company.
Expected May 2, After Hours